Prognostic factors in univariate analyses
. | 3-year OS, % . | P . |
|---|---|---|
| Sex | .70 | |
| Male | 47.7 | |
| Female | 53.1 | |
| Age at transplantation | .0036 | |
| Less than 40 y | 57.1 | |
| 40 y or more | 28.7 | |
| Histology | .80 | |
| Low grade | 60.0 | |
| Intermediate grade | 53.2 | |
| High grade | 47.6 | |
| Previous HDT/ASCT | .0006 | |
| Yes | 27.8 | |
| No | 56.3 | |
| Chemosensitivity | < .0001 | |
| Chemosensitive | 63.2 | |
| Chemoresistant | 22.8 | |
| Disease status | .0011 | |
| CR | 61.4 | |
| Non-CR | 32.0 | |
| Preparative regimen | .29 | |
| TBI-containing | 50.8 | |
| Non-TBI | 40.0 | |
| Days from diagnosis to transplantation | .53 | |
| Less than 365 d | 44.8 | |
| 365 d or more | 52.1 |
. | 3-year OS, % . | P . |
|---|---|---|
| Sex | .70 | |
| Male | 47.7 | |
| Female | 53.1 | |
| Age at transplantation | .0036 | |
| Less than 40 y | 57.1 | |
| 40 y or more | 28.7 | |
| Histology | .80 | |
| Low grade | 60.0 | |
| Intermediate grade | 53.2 | |
| High grade | 47.6 | |
| Previous HDT/ASCT | .0006 | |
| Yes | 27.8 | |
| No | 56.3 | |
| Chemosensitivity | < .0001 | |
| Chemosensitive | 63.2 | |
| Chemoresistant | 22.8 | |
| Disease status | .0011 | |
| CR | 61.4 | |
| Non-CR | 32.0 | |
| Preparative regimen | .29 | |
| TBI-containing | 50.8 | |
| Non-TBI | 40.0 | |
| Days from diagnosis to transplantation | .53 | |
| Less than 365 d | 44.8 | |
| 365 d or more | 52.1 |
OS indicates overall survival; HDT/ASCT, high-dose therapy and autologous stem cell transplantation; CR, complete remission; TBI, total body irradiation.